Loading…
Evidence for reduced neuromuscular function in men with a history of androgen deprivation therapy for prostate cancer
Summary Background Indices of body composition and muscular strength were compared between men with prostate cancer (PCa) treated with androgen deprivation therapy (ADT) and asymptomatic matched men. Methods Nine subjects aged 63–83 years with PCa who received ADT (PCa+ADT; duration 6–180 months) an...
Saved in:
Published in: | Clinical physiology and functional imaging 2014-05, Vol.34 (3), p.209-217 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Summary
Background
Indices of body composition and muscular strength were compared between men with prostate cancer (PCa) treated with androgen deprivation therapy (ADT) and asymptomatic matched men.
Methods
Nine subjects aged 63–83 years with PCa who received ADT (PCa+ADT; duration 6–180 months) and 11 asymptomatic aged‐matched eugonadal men (HM) aged 59–80 years were assessed for prostate‐specific antigen (PSA) and total testosterone (TT). Total body non‐osseous lean mass (TBLM) and right thigh non‐osseous fat‐free mass (RTLM) were assessed using dual‐energy X‐ray absorptiometry. Peak torque of the right knee extensors at 0° s−1 (ISO) and 60° s−1 (CON), maximal handgrip strength of the dominant hand (MHS) and whole‐body strength (WBS) were assessed. ISO and CON per unit mass of RTLM and MHS and WBS per unit mass of TBLM were calculated.
Results
Age, height, mass, body mass index and prostate‐specific antigen were comparable between groups (P>0·05), while TT was lower in PCa+ADT (P |
---|---|
ISSN: | 1475-0961 1475-097X |
DOI: | 10.1111/cpf.12084 |